EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ceramide‐mediated mitochondrial dysfunction in nonobese nonalcoholic fatty liver disease: A regulatory role for serine palmitoyltransferase subunit 2

Li-Jun Xue, Guang-Yan Yao, Fei-Fei Fan, Kai-Min Li, Wen-Ming Wu iD

Journal of Cell Communication and Signaling · 2026-06 · 20 (2)

DOI: 10.1002/ccs3.70091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Communication and Signaling, online erschienen am 25.06.2026. Verfasst von Li-Jun Xue und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology Jinan Central Hospital Affiliated to Shandong First Medical University Jinan Shandong China. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the pathological relevance of the serine palmitoyltransferase long chain base subunit 2 (Sptlc2)–ceramide axis in nonobese nonalcoholic fatty liver disease (NAFLD), focusing on hepatic steatosis, inflammation, oxidative stress, and mitochondrial dysfunction. A nonobese NAFLD rat model was established using a high‐temperature dry‐fried soybean diet. Integrated liquid chromatography‐mass spectrometry‐based proteomic and metabolomic analyses were used to identify candidate pathways. Sptlc2 function was validated by AAV2/8‐mediated liver‐directed knockdown in vivo, lentiviral knockdown in primary hepatocytes, and C2‐ceramide rescue experiments. Multi‐omics profiling identified Sptlc2 as a sphingolipid metabolism‐related candidate in the model. Sptlc2 knockdown reduced long‐chain ceramide accumulation, hepatic lipid deposition, inflammatory cytokine expression, oxidative stress, and hepatocyte injury. In primary hepatocytes, Sptlc2 silencing improved mitochondrial respiration, membrane potential, calcium and reactive oxygen species homeostasis, and mitochondrial ultrastructure. These protective effects were partially reversed by C2‐ceramide in vitro and in vivo. The Sptlc2–ceramide axis contributes to ceramide accumulation, hepatic lipotoxicity, inflammatory activation, and mitochondrial dysfunction in this nonobese NAFLD model, suggesting its potential relevance as a therapeutic target for further investigation.

Schlagwörter

Stichwörter der Autor:innen

Sptlc2ceramidemitochondrial dysfunctionnon‐obese NAFLDprecision therapy

Autor:innen und Institutionen

  • Department of Gastroenterology Jinan Central Hospital Affiliated to Shandong First Medical University Jinan Shandong China.
  • Department of Gastroenterology and Hepatology The 960(th) Hospital of Joint Logistics Support Force PLA Jinan Shandong China.
  • Department of Gastroenterology China-Japan Friendship Hospital Beijing China.

ORCID-Profile: Wen-Ming Wu

Zitieren

APA

Xue, L. J., Yao, G. Y., Fan, F. F., Li, K. M., & Wu, W. M. (2026). Ceramide‐mediated mitochondrial dysfunction in nonobese nonalcoholic fatty liver disease: A regulatory role for serine palmitoyltransferase subunit 2. Journal of Cell Communication and Signaling, 20(2). https://doi.org/10.1002/ccs3.70091

Vancouver

Xue LJ, Yao GY, Fan FF, Li KM, Wu WM. Ceramide‐mediated mitochondrial dysfunction in nonobese nonalcoholic fatty liver disease: A regulatory role for serine palmitoyltransferase subunit 2. Journal of Cell Communication and Signaling. 2026;20(2). doi:10.1002/ccs3.70091

BibTeX
@article{Xue2026,
  author = {Xue, Li-Jun and Yao, Guang-Yan and Fan, Fei-Fei and Li, Kai-Min and Wu, Wen-Ming},
  title = {Ceramide‐mediated mitochondrial dysfunction in nonobese nonalcoholic fatty liver disease: A regulatory role for serine palmitoyltransferase subunit 2},
  journal = {Journal of Cell Communication and Signaling},
  year = {2026},
  volume = {20},
  number = {2},
  doi = {10.1002/ccs3.70091}
}
Kostenlos starten →